Can Parvovirus B19 infection be naturally oncolytic: clinical findings raise such a possibility in leukaemic children.
作者信息
Kishore Janak, Kishor Divya
机构信息
Department of Microbiology Sanjay Gandhi Post Graduate Institute of Medical Sciences Lucknow 226 014, India.
出版信息
Indian J Med Res. 2014 Jun;139(6):952-3.
Abstract
摘要
相似文献
1
Can Parvovirus B19 infection be naturally oncolytic: clinical findings raise such a possibility in leukaemic children.
Indian J Med Res. 2014 Jun;139(6):952-3.
2
Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection.
J Med Virol. 2006 Jan;78(1):125-8. doi: 10.1002/jmv.20513.
3
Aplastic anaemia associated with parvovirus B19 infection.
Arch Dis Child. 2002 Nov;87(5):436-7. doi: 10.1136/adc.87.5.436.
4
[Various clinical symptoms in human parvovirus B19 infection].
Nihon Rinsho Meneki Gakkai Kaishi. 2008 Dec;31(6):448-53. doi: 10.2177/jsci.31.448.
5
Molecular Study of Parvovirus B19 Infection in Children with Acute Myeloid Leukemia.
Asian Pac J Cancer Prev. 2018 Feb 26;19(2):337-342. doi: 10.22034/APJCP.2018.19.2.337.
6
Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia.
Lancet. 1988 Nov 19;2(8621):1159-62. doi: 10.1016/s0140-6736(88)90233-4.
7
A Roadmap for the Success of Oncolytic Parvovirus-Based Anticancer Therapies.
Annu Rev Virol. 2020 Sep 29;7(1):537-557. doi: 10.1146/annurev-virology-012220-023606. Epub 2020 Jun 29.
8
The role of parvovirus B19 infection in childhood acute lymphoblastic leukemia.
Pediatr Hematol Oncol. 1999 Jul-Aug;16(4):329-34. doi: 10.1080/088800199277155.
9
Acute transverse myelitis associated with human parvovirus b19 infection.
J Child Neurol. 2014 Feb;29(2):280-2. doi: 10.1177/0883073813499824. Epub 2013 Sep 18.
10
Clinical and hematological study for Parvovirus b19 infection in children with acute leukemia.
Int J Lab Hematol. 2010 Apr;32(2):159-66. doi: 10.1111/j.1751-553X.2009.01150.x. Epub 2009 Feb 26.
引用本文的文献
1
Clinical impact & pathogenic mechanisms of human parvovirus B19: A multiorgan disease inflictor incognito.
Indian J Med Res. 2018 Oct;148(4):373-384. doi: 10.4103/ijmr.IJMR_533_18.
2
Association of the Human Bocavirus With Tonsil Squamous Cell Carcinomas.
Front Microbiol. 2018 Oct 16;9:2450. doi: 10.3389/fmicb.2018.02450. eCollection 2018.
3
Detection of parvovirus B19 in selected high-risk patient groups & their phylogenetic & selection analysis.
Indian J Med Res. 2018 Apr;147(4):391-399. doi: 10.4103/ijmr.IJMR_241_16.
4
The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers.
Front Oncol. 2017 May 12;7:93. doi: 10.3389/fonc.2017.00093. eCollection 2017.
5
Gene and virotherapy for hematological malignancies.
Int J Hematol. 2016 Jul;104(1):29-41. doi: 10.1007/s12185-016-2031-1. Epub 2016 Jun 11.
本文引用的文献
1
Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas.
EMBO Mol Med. 2013 Oct;5(10):1537-55. doi: 10.1002/emmm.201302796. Epub 2013 Sep 17.
2
Natural oncolytic activity of live-attenuated measles virus against human lung and colorectal adenocarcinomas.
Biomed Res Int. 2013;2013:387362. doi: 10.1155/2013/387362. Epub 2013 Mar 17.
3
Parvoviruses-tools to fine-tune anticancer immune responses.
Oncoimmunology. 2012 Nov 1;1(8):1417-1419. doi: 10.4161/onci.21097.
4
Oncolytic viruses & their specific targeting to tumour cells.
Indian J Med Res. 2012 Oct;136(4):571-84.
5
Activation of the human immune system via toll-like receptors by the oncolytic parvovirus H-1.
Int J Cancer. 2013 Jun 1;132(11):2548-56. doi: 10.1002/ijc.27938. Epub 2012 Nov 29.
6
Viruses in cancer treatment.
Clin Transl Oncol. 2013 Mar;15(3):182-8. doi: 10.1007/s12094-012-0951-7. Epub 2012 Nov 10.
7
Molecular pathways: rodent parvoviruses--mechanisms of oncolysis and prospects for clinical cancer treatment.
Clin Cancer Res. 2012 Jul 1;18(13):3516-23. doi: 10.1158/1078-0432.CCR-11-2325. Epub 2012 May 7.
8
Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol.
BMC Cancer. 2012 Mar 21;12:99. doi: 10.1186/1471-2407-12-99.
9
A pilot study on parvovirus B19 infection in paediatric haematological malignancies.
Indian J Med Res. 2011 Apr;133(4):407-13.
10
Measles virotherapy in a mouse model of adult T-cell leukaemia/lymphoma.
J Gen Virol. 2011 Jun;92(Pt 6):1458-1466. doi: 10.1099/vir.0.028910-0. Epub 2011 Feb 16.
Zotero 插件